JOHNSON FINANCIAL GROUP, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
JOHNSON FINANCIAL GROUP, INC. portfolio value:
$856,000
portfolio value
JOHNSON FINANCIAL GROUP, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -15.39% | -209 shares | 53K | $688.87 | 1.14K |
| Q2 2022 | share | Increase | +2.72% | 36 shares | -120K | $591.13 | 1.35K |
| Q1 2022 | share | Increase | +4.26% | 54 shares | 122K | $698.42 | 1.32K |
| Q4 2021 | share | Increase | +9.78% | 113 shares | 102K | $642.51 | 1.26K |
| Q3 2021 | share | Decrease | -7.30% | -91 shares | 3K | $605.18 | 1.15K |
| Q2 2021 | share | Increase | +11.65% | 130 shares | 168K | $558.54 | 1.24K |
| Q1 2021 | share | Decrease | -4.12% | -48 shares | -34K | $473.14 | 1.11K |
| Q4 2020 | share | Decrease | -3.00% | -36 shares | -110K | $483.11 | 1.16K |
| Q3 2020 | share | Increase | +22.32% | 219 shares | 60K | $559.78 | 1.2K |
| Q2 2020 | share | Decrease | -9.59% | -104 shares | 82K | $623.65 | 981 |
| Q1 2020 | share | Decrease | -2.34% | -26 shares | 113K | $488.29 | 1.08K |
| Q3 2019 | share | Increase | +9.15% | 270 shares | -30K | $277.4 | 3.22K |
| Q2 2019 | share | Increase | +30.06% | 682 shares | -8K | $313 | 2.95K |
| Q1 2019 | share | Increase | +18.30% | 351 shares | 215K | $410.62 | 2.26K |
| Q4 2018 | share | Increase | +3736.00% | 1.86K shares | 696K | $373.5 | 1.91K |
| Q3 2018 | share | 0.00% | 0 shares | 3K | $404.04 | 50 | |
| Q2 2018 | share | 0.00% | 0 shares | 0 | $344.99 | 50 | |
| Q1 2018 | share | 0.00% | 0 shares | -2K | $344.36 | 50 | |
| Q4 2017 | share | 0.00% | 0 shares | -3K | $375.96 | 50 | |
| Q3 2017 | share | 0.00% | 0 shares | -3K | $447.12 | 50 | |
| Q2 2017 | share | Decrease | -54.13% | -59 shares | -17K | $491.14 | 50 |
| Q1 2017 | share | Increase | +15.96% | 15 shares | 8K | $387.51 | 109 |
| Q4 2016 | share | Decrease | -51.55% | -100 shares | -44K | $367.09 | 94 |
| Q3 2016 | share | Increase | +4.86% | 9 shares | 14K | $402.02 | 194 |
| Q2 2016 | share | Decrease | -24.49% | -60 shares | -24K | $349.23 | 185 |
| Q1 2016 | share | Decrease | -9.26% | -25 shares | -59K | $360.44 | 245 |